← Every firm
NATCO Pharma Limited FDA Recalls
2 recalls on file across drugs, 0 of them Class I and 0 still open. This firm is not matched to a listed company.
Newest first
Class I is the FDA's most serious grade: a reasonable probability of serious harm or death.
| Product |
|---|
| Lansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 14 capsules per bottlClass IIMar 27, 2024CGMP Deviations |
| Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228Class IIFeb 1, 2024CGMP Deviations: Inadequate induction sealing on bottles, ca |